Prof. Michael Glickman will receive the grant for researching “The origin and impact of impaired ubiquitin signaling in the degeneration of neurons”. He and his team have developed an innovative model for studying Alzheimer’s disease using nerve cells derived from human stem cells.
The research they propose is based on their hypothesis that impairment of the ubiquitin system, responsible for clearing cells of damaged proteins, could lead to the development of Alzheimer’s disease. With the help of their innovative experimental model, the grant will enable the laboratory to identify the specific component in the ubiquitin system that contributes to the development of the disease in its early stages. The long-term aim is to develop original treatments to repair brain damage in Alzheimer’s patients
Michael, congratulations to you and your team for this remarkable achievement!
Continue to succeed and inspire, both as a scientist and as a dean.
On behalf of the faculty.
